CADILA PHARMACEUTICALS, LTD

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 14241
 
  
 
C07D HETEROCYCLIC COMPOUNDS 2160
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0042,850 Pharmaceutical Composition of Killed Cells with Substantially Retained ImmunogenicityOct 02, 17Feb 15, 18[A61K, C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9795659 Pharmaceutical composition of killed cells with substantially retained immunogenicityFeb 17, 11Oct 24, 17[A61K, A01N]
9789187 Stable pharmaceutical composition for atherosclerosisFeb 08, 10Oct 17, 17[A61K]
9714275 Cancer antigenJul 04, 12Jul 25, 17[A61K, C07K]
9708258 Indole 3-carbinol derivativesJul 11, 14Jul 18, 17[C07D]
9474727 Pharmaceutical compositions of curcuminSep 12, 11Oct 25, 16[A61K]
9415078 English Title Not AvailableFeb 23, 15Aug 16, 16[A61K, C12N]
9345683 Pharmaceutical composition of taxoidsNov 05, 11May 24, 16[A61K, A01N]
9029567 Hypoglycemic compoundsApr 01, 11May 12, 15[A61K, C07D]
8563517 Dipeptidyl peptidase IV (DP-IV) compoundsSep 11, 09Oct 22, 13[A61K, C07K]
8333978 Poly TLR antagonistNov 21, 07Dec 18, 12[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0045,771 NOVEL DIPEPTIDYL PEPTIDASE IV (DP-IV) COMPOUNDSAbandonedOct 21, 13Feb 13, 14[C07K]
8647643 Farnesoid-X-receptor antagonist as a vaccine adjuvantExpiredSep 26, 09Feb 11, 14[A61K]
2013/0330,375 Therapeutic Cancer VaccineAbandonedFeb 27, 12Dec 12, 13[A61K]
2013/0295,648 PHARMACEUTICAL COMPOSITION FOR TREATING CANCERAbandonedJan 10, 12Nov 07, 13[A61K, C12N]
2013/0137,852 NOVEL COMPOUNDS AS DPP-IV INHIBITORS AND PROCESS FOR PREPARATION THEREOFAbandonedAug 03, 11May 30, 13[C07D, C07K]
2012/0328,574 P38 INHIBITORSAbandonedJun 28, 12Dec 27, 12[A61K, A61P]
8277778 Vaccine adjuvantsExpiredSep 23, 11Oct 02, 12[A61K, G01N]
8153102 in the treatment of asthma (obstructive lung disease)ExpiredMar 11, 03Apr 10, 12[A61K]
8110204 Method of treating human-immunodeficiency virus (HIV) disease infectionExpiredJan 17, 02Feb 07, 12[A61K, A01N]
2011/0020,440 STABLE SOLUTIONS OF SPARINGLY SOLUBLE ACTIVESAbandonedNov 15, 08Jan 27, 11[A61K, A61P]
2010/0209,394 MITOGEN ACTIVATED PROTEIN KINASE MODULATORAbandonedJun 26, 08Aug 19, 10[A61K, C12N, A61P]
2010/0113,802 PROCESS FOR PREPARING AMORPHOUS ATORVASTATIN HEMI CALCIUM SALT AND ITS ITERMEDIATEAbandonedOct 29, 07May 06, 10[C07D]
2010/0104,536 P38 INHIBITORSAbandonedMar 18, 08Apr 29, 10[A61K, C12N, C07K]
2009/0177,008 NOVEL PROCESS FOR SYNTHESIS OF ITOPRIDE AND ITS NOVEL INTERMEDIATE N-(4-HYDROXYBENZYL)- 3,4-DIMETHOXYBENZAMIDEAbandonedDec 28, 06Jul 09, 09[C07C]
2009/0137,633 Stable pharmaceutical composition of rabeprazoleAbandonedAug 02, 04May 28, 09[A61K]
2008/0091,022 PREPARATION FOR METHSCOPOLAMINE TANNATEAbandonedOct 10, 07Apr 17, 08[C07D]
2007/0249,839 Process for the Preparation of Losartan Potassium Form IAbandonedOct 31, 06Oct 25, 07[C07D]
2002/0025,309 Stable oral pharmaceutical formulation containing an anti-infective agent and a microorganismAbandonedAug 23, 01Feb 28, 02[A61K]
6306391 Preparation of an oral pharmaceutical formulation containing an anti-infective agent and a microorganismExpiredMar 23, 98Oct 23, 01[A01N, C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.